KMT2A and neoplasm: Menin has a tumor-suppressor function in endocrine glands and is critical for leukemogenesis in a subgroup of mixed-lineage leukemia (MLL), driven by the rearrangement of the KMT2A gene, which encodes an epigenetic modifier.